Is Biohaven Pharmaceutical Holding Co Ltd (BHVN) a Leader in the Biotechnology Industry?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) is around the top of the Biotechnology industry according to InvestorsObserver. BHVN received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Biohaven Pharmaceutical Holding Co Ltd also achieved a score of 71 in the Biotechnology industry, putting it above 71 percent of Biotechnology stocks. Biotechnology is ranked 16 out of the 148 industries.

BHVN has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on BHVN!

See Full BHVN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Biohaven Pharmaceutical Holding Co Ltd Stock Today?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock is trading at $7.80 as of 12:56 PM on Tuesday, Oct 4, an increase of $0.80, or 11.43% from the previous closing price of $7.00. The stock has traded between $7.10 and $8.50 so far today. Volume today is high. So far 6,203,571 shares have traded compared to average volume of 978,234 shares. Click Here to get the full Stock Report for Biohaven Pharmaceutical Holding Co Ltd stock.